BIRMINGHAM, Ala. – March 11, 2015 – Southern Research – developer of seven FDA-approved cancer drugs – will be exhibiting at the Society of Toxicology (SOT) 54th Annual Meeting and ToxExpo, March 22 – 26, 2015, in San Diego, at booth #1301.
A science-driven, client-focused, preclinical contract research organization, Southern Research has more than 50 years of experience in drug development. Services include efficacy testing, with special expertise in anti-cancer drugs and anti-infective drugs (antibacterial and antiviral, supported by BSL-2 and BSL-3 laboratories and animal facilities), and a complete range of safety testing, including reproductive toxicology, with extensive bioanalytical, PCR and anatomic/clinical pathology facilities.
Utilizing comprehensive, in-house in vitro and in vivo capabilities, Southern Research’s experienced scientists work closely with clients in providing expert guidance and advice during all phases of preclinical development. A key hallmark of its program is the capability to provide custom-designed assays and studies to meet clients’ specific research needs.
In 2014, Southern Research, along with four other research organizations, formed the Southern Biologics Network (SBN) to create advanced biologics faster and less expensively for biopharmaceutical companies of all sizes. SBN provides comprehensive biologic development services, which include the manufacture, discovery, preclinical development, and early-stage clinical development of biologics.
Most recently, Southern Research expanded preclinical service offerings in drug development with the addition of GLP-compliant in vitro safety pharmacology testing on CytoPatch™. With the CytoPatch system, Southern Research successfully demonstrated in vitro hERG ion channel blocking by drug candidates at a physiologically relevant 37 degrees Celsius.
In addition to its scope of drug development services, Southern Research also offers pharmaceutical consulting in formulation, processing, manufacturing, and business operations.
Please visit Southern Research at booth #1301 to meet Director of Business Development Robin Akers, who will be able to answer your questions and discuss new business opportunities.
Founded in 1961, the Society of Toxicology (SOT) is a professional and scholarly organization of more than 7,800 scientists from academic institutions, government, and industry representing the great variety of individuals who practice toxicology in the U.S. and abroad. SOT is committed to creating a safer and healthier world by advancing the science of toxicology. SOT promotes the acquisition and utilization of knowledge in toxicology, aids in the protection of public health, and has a strong commitment to education in toxicology and to the recruitment of students and new members into the profession. For more information about SOT and toxicology, visit www.toxicology.org.
About Southern Research
Founded in 1941 in Birmingham, Alabama, Southern Research is a not-for-profit 501(c)(3) scientific and engineering research organization that conducts preclinical drug discovery and development, advanced engineering research in materials, systems development, and energy and environment research. Approximately 500 team members support clients and partners in the pharmaceutical, biotechnology, defense, aerospace, environmental, and energy industries in facilities in Alabama, Maryland, North Carolina, Georgia, and Texas.